AstraZeneca said Monday its experimental pill ... This isn't the first time PCSK9 blockers have been in the limelight. Makar expects the daily pills to have an easier commercial time.

AstraZeneca has agreed to pay up to $2 billion for an experimental pill used to treat obesity and type 2 diabetes—the latest pharmaceutical firm to bet on treatment similar to popular weight ...

A replacement for a key COVID-19 antibody drug that has been used to protect immunocompromised Americans could be available within months, executives for drugmaker AstraZeneca said Thursday ...